Acetyl-L-Carnitine in the Treatment of Septic Shock

• Status: Completed
• Trial end date: 2009-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This placebo-controlled study investigates acetyl-L-carnitine in the treatment of septic shock requiring vasopressors.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Vanderbilt University; Vanderbilt University Medical Center
• Treatments: Acetylcarnitine

Criteria

Inclusion Criteria:

• documented or presumed infection

• shock requiring vasopressors

Exclusion Criteria:

• dialysis

• hepatic failure

• seizures